Imaging-guided precision medicine in glioblastoma patients treated with immune checkpoint modulators: research trend and future directions in the field of imaging biomarkers and artificial intelligence

Immunotherapies that employ immune checkpoint modulators (ICMs) have emerged as an effective treatment for a variety of solid cancers, as well as a paradigm shift in the treatment of cancers. Despite this breakthrough, the median survival time of glioblastoma patients has remained at about 2 years....

Descripción completa

Detalles Bibliográficos
Autores principales: Sinigaglia, Mathieu, Assi, Tarek, Besson, Florent L., Ammari, Samy, Edjlali, Myriam, Feltus, Whitney, Rozenblum-Beddok, Laura, Zhao, Binsheng, Schwartz, Lawrence H., Mokrane, Fatima-Zohra, Dercle, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702257/
https://www.ncbi.nlm.nih.gov/pubmed/31432278
http://dx.doi.org/10.1186/s13550-019-0542-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702257/
https://www.ncbi.nlm.nih.gov/pubmed/31432278
http://dx.doi.org/10.1186/s13550-019-0542-5

Ejemplares similares